Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
QNRX — Quoin Pharmaceuticals, Ltd.
NASDAQ
FULL STOCK PAGE →

Q4 2023 Earnings Call Summary

MAR 14, 2024
REVENUE
$0
EPS
-$2571.15 -7.9%
FREE CASH FLOW
-$3.2M -143.9%

No summary has been written for this call yet.